Navigation Links
GeNO LLC Announces Senior Management Appointment
Date:8/27/2013

WALTHAM, Mass., Aug. 27, 2013 /PRNewswire/ -- GeNO LLC, a privately-held biopharmaceutical company focused on the design, development and commercialization of next-generation products to address unmet medical needs of patients with a variety of pulmonary and cardiac diseases, today announced that Kurt A. Dasse, Ph.D., currently serving as president and a member of the company's Board of Managers, has been appointed CEO of the Company.  Dr. David Fine will continue to serve GeNO as executive chairman and chief scientific officer.

"Dr. Dasse has significant international experience with the use of inhaled nitric oxide to minimize the risk of right heart failure following the treatment of patients undergoing the implantation of Left Ventricular Assist Devices (LVADs). This appointment will strengthen the company's focus on developing and obtaining regulatory approvals for its innovative and cost-effective platforms for generating nitric oxide therapy in the treatment of multiple diseases and conditions," said David Fine, GeNO founder and executive chairman. "I am thrilled to hand over the role of CEO to Kurt."

"I believe GeNO is well positioned to make a significant impact on the medical treatment of patients worldwide who suffer from pulmonary and cardiac diseases," said Dasse. "I am honored and excited to lead a highly talented group at GeNO committed to delivering the next generation of inhaled nitric oxide products, including a portable solution, designed to benefit a large patient population."

Dasse, who will continue to serve on the company's Board of Managers, has spent nearly 30 years researching and developing therapies for cardiopulmonary disorders, and has developed and commercialized devices and therapies for the treatment of heart, lung and renal failure. He joined GeNO as a member of the Board of Managers in 2
'/>"/>

SOURCE GeNO LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Sihuan Pharmaceutical Announces 2013 Interim Results
2. Echo Therapeutics Announces Management Changes
3. ConvaTec Announces 2013 Second Quarter Earnings Call
4. Sam Solakyan, CEO of Vital Imaging Announces purchase of cutting edge equipment
5. Yew Bio-Pharm Group Announces Coverage by S&P Capital IQ
6. Cellular Biomedicine Group Announces Completion of Patient Enrollment for Phase I Clinical Trial for Liver Cancer
7. Avanir Pharmaceuticals Announces Publication of PRISM Pseudobulbar Affect Registry Findings
8. Regado Biosciences, Inc. Announces Pricing of Initial Public Offering
9. VirtualScopics Announces 1-for-10 Reverse Stock Split
10. Allscripts Announces Winners of the Open App Challenge
11. CryoLife Announces Quarterly Cash Dividend for the Third Quarter 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... 27, 2015  Finesse expands office in Leicester, ... the expansion of its operations in Leicester ... and access for customers is expected shortly afterward. ... adjacent to the current office, the new premises will ... and allow Finesse to bring on more service personnel. ...
(Date:2/26/2015)... , Feb. 26, 2015  Tandem Diabetes Care®, ... company and manufacturer of the t:slim® and t:flex™ Insulin ... offering of 5,250,000 shares of its common stock at ... The net proceeds to Tandem from this offering are ... and commissions and other estimated offering expenses payable by ...
(Date:2/26/2015)... , Feb. 26, 2015  Today the National ... The psychological and physical side effects of pain medications ... painkillers, such as Vicodin and Oxycontin, are safer options ... overdose on prescription painkillers than on heroin and cocaine ... CEO of NSC. "Yet, these medications are marketed as ...
Breaking Medicine Technology:New Finesse Office in United Kingdom 2Tandem Diabetes Care Announces Pricing of Underwritten Public Offering of Common Stock 2Tandem Diabetes Care Announces Pricing of Underwritten Public Offering of Common Stock 3National Safety Council: Opioid prescription painkillers have hidden, deadly side effects 2
(Date:2/27/2015)... MD (PRWEB) February 27, 2015 ... (Meso Foundation) and the National Cancer Institute (NCI) ... Mesothelioma at the National Institutes of Health (NIH), ... one part is dedicated to medical professionals and ... is directed to the general public, including patients, ...
(Date:2/27/2015)... In honor of American Heart Month in February, ... office, is offering tips on how to improve heart health. , ... doesn't mean people have to accept it as their fate. Although ... such as family history, sex or age — there are some ... has six helpful tips to improve heart health and prevent heart ...
(Date:2/27/2015)... Royal River Natural Foods, a locally-owned independent natural health ... adults who got the most magnesium were less than half ... who got the least magnesium, with the largest benefit in ... part of the March 2015 issue of “ Natural Insights ... free each month for the Freeport community to learn more ...
(Date:2/27/2015)... Beach, FL (PRWEB) February 27, 2015 ... medical companies, devices and pharmaceuticals, Benedict Advertising & ... as its newest client. The company’s patented NITROUSEAL® ... a pain-free, no-stress method of sedation. , Sedation ... medical patient comfort to a new level, though ...
(Date:2/27/2015)... FACE Skincare~Medical~Wellness, a multiaward-winning leader in ... combination to take fifteen years off of an ... new treatment introduced that is the first and ... improve lines and wrinkles on the Décolleté. This ... from the stubborn vertical lines between the upper ...
Breaking Medicine News(10 mins):Health News:Conference on Mesothelioma Co-Hosted with National Cancer Institute 2Health News:Conference on Mesothelioma Co-Hosted with National Cancer Institute 3Health News:Center for Primary Care Celebrates American Heart Month 2Health News:Center for Primary Care Celebrates American Heart Month 3Health News:Center for Primary Care Celebrates American Heart Month 4Health News:New Study Finds Magnesium May Slow Progress of Diabetes, Retailer Reports 2Health News:Benedict Advertising & Marketing Signs Sedation Systems 2Health News:Face Skincare Announces New Combination Therapy 2
... KING OF PRUSSIA, PA, Jan. 7 /PRNewswire-FirstCall/ - ... drug discovery and development solutions, today announced the ... Chief Financial Officer. , Mr. Howard has extensive ... pharmaceutical and contract research organization (CRO) industry sectors, ...
... Inverness Medical Innovations, Inc. (NYSE: IMA ), ... management solutions, has introduced the pima(TM) analyzer, a ... Point-of-Care. The initial application of the instrument will be ... The instrument is one of several novel technologies under ...
... New office will provide marketing support to improve awareness ... 7 Daiichi Sankyo, Inc., announced today that it ... Rico, Inc. Daiichi Sankyo de Puerto Rico, Inc. ... Vazquez, Regional Director -- Puerto Rico, who has more ...
... /PRNewswire-FirstCall/ - Hard to Treat Diseases (HTDS) www.htdsmedical.com ... has identified a cosmetics company as a potential merger ... (Serbia) is engaged in online sales of the "Melem" ... balm. It has a wide variety of skin and ...
... Intellect Neurosciences, Inc. ( OTC Bulletin Board: ILNS ... disease-modifying therapeutic agents for the treatment and prevention ... has granted a non-exclusive License to a top-tier ... and patent applications related to antibodies and methods ...
... WINSTON-SALEM, N.C., Jan. 7 We,ve all been there: ... minutes, even an hour or more.,But when a long ... doctor,that,s when the frustration sets in. , ... don,t spend enough time with,them, the combination of factors ...
Cached Medicine News:Health News:MDS Pharma Services Names Rudy Howard Chief Financial Officer 2Health News:Inverness Medical Innovations Presents the pima(TM) Point-of-Care CD4 Instrument at ICASA 2008 2Health News:Inverness Medical Innovations Presents the pima(TM) Point-of-Care CD4 Instrument at ICASA 2008 3Health News:Daiichi Sankyo, Inc. Establishes Subsidiary in Puerto Rico 2Health News:Hard To Treat Diseases (HTDS) Set To Acquire Cosmetics Company 2Health News:Intellect Neurosciences, Inc. Grants to Top Tier Global Pharmaceutical Company License to Certain Alzheimer's Patents and Patent Applications 2Health News:Intellect Neurosciences, Inc. Grants to Top Tier Global Pharmaceutical Company License to Certain Alzheimer's Patents and Patent Applications 3Health News:Intellect Neurosciences, Inc. Grants to Top Tier Global Pharmaceutical Company License to Certain Alzheimer's Patents and Patent Applications 4Health News:Intellect Neurosciences, Inc. Grants to Top Tier Global Pharmaceutical Company License to Certain Alzheimer's Patents and Patent Applications 5Health News:DrScore.com Identifies 'Toxic Combination' 2
Chase micro-hemocrit tubes are manufactured from soda lime glass, packed in plastic vials with reclosable snap-lock caps to maintain cleanliness....
Hemato-clad Hematocrit Tubes combine the precision of glass with the safety provided by a Mylar® overwrap. Now you can give your laboratory staff safety with no compromise in accuracy....
... capillary tubes help protect healthcare workers from ... common medical procedures. Each BD plastic-coated micro-hematocrit ... so thin that it does not interfere ... inspection of the sample. The mylar film ...
... In the Innova™ 4100, the ... X-ray system for angiographic imaging, ... piece, non tiled Digital Detector ... reliably provide high resolution imaging ...
Medicine Products: